{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:17:25Z","timestamp":1789805845409,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.tracli.2017.05.014","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T10:20:08Z","timestamp":1498040408000},"page":"160-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antiplaquettaires et transfusion"],"prefix":"10.1016","volume":"24","author":[{"given":"P.","family":"Gaussem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-C.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Belleville-Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Helley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bachelot-Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Godier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2017.05.014_bib0155","first-page":"51","article-title":"Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers","volume":"6","author":"Nagelschmitz","year":"2014","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.tracli.2017.05.014_bib0160","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2017.05.014_bib0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jth.12445","article-title":"Clinical implications of drug-drug interactions with P2Y12\u00a0receptor inhibitors","volume":"12","author":"Siller-Matula","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tracli.2017.05.014_bib0170","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ahj.2008.06.004","article-title":"Pharmacology of emerging novel platelet inhibitors","volume":"156","author":"Angiolillo","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.tracli.2017.05.014_bib0175","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2017.05.014_bib0180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.thromres.2006.11.012","article-title":"Measuring antiplatelet drug effects in the laboratory","volume":"120","author":"Harrison","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.tracli.2017.05.014_bib0185","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.athoracsur.2016.05.003","article-title":"Does platelet reactivity predict bleeding in patients needing urgent coronary artery bypass grafting during dual antiplatelet therapy?","volume":"102","author":"Mahla","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.tracli.2017.05.014_bib0190","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1538-7836.2009.03709.x","article-title":"Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement","volume":"8","author":"Sibbing","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tracli.2017.05.014_bib0195","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/bja\/aew357","article-title":"Prospective observational study of the effect of dual antiplatelet therapy with tranexamic acid treatment on platelet function and bleeding after cardiac surgery","volume":"117","author":"Amour","year":"2016","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.tracli.2017.05.014_bib0200","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijcard.2016.01.102","article-title":"The challenge for predicting bleeding events by assessing platelet reactivity following coronary stenting","volume":"207","author":"Choi","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tracli.2017.05.014_bib0205","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/bja\/aew189","article-title":"Preoperative platelet function predicts perioperative-bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study","volume":"117","author":"Malm","year":"2016","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.tracli.2017.05.014_bib0210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology","volume":"30","author":"Kozek-Langenecker","year":"2013","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.tracli.2017.05.014_bib0215","series-title":"Transfusion de plaquettes: produits, indications","first-page":"1","author":"ANSM","year":"2015"},{"key":"10.1016\/j.tracli.2017.05.014_bib0220","article-title":"[Management of the bleeding risk associated with antiplatelet agents]","author":"Martin","year":"2017","journal-title":"Rev Med Intern"},{"key":"10.1016\/j.tracli.2017.05.014_bib0225","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/EJA.0000000000000348","article-title":"The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: An in-vitro study","volume":"33","author":"Martin","year":"2016","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.tracli.2017.05.014_bib0230","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01586154-201305000-00027","article-title":"Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and\/or clopidogrel before emergency surgery?","volume":"74","author":"Taylor","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.tracli.2017.05.014_bib0235","doi-asserted-by":"crossref","first-page":"e002786","DOI":"10.1161\/CIRCINTERVENTIONS.115.002786","article-title":"Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12\u00a0inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study","volume":"8","author":"O\u2019Connor","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tracli.2017.05.014_bib0240","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/jth.13511","article-title":"Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjects","volume":"14","author":"Teng","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tracli.2017.05.014_bib0245","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/jth.12058","article-title":"Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation","volume":"11","author":"Zafar","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tracli.2017.05.014_bib0250","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/09537104.2015.1035247","article-title":"Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study","volume":"26","author":"Bonhomme","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.tracli.2017.05.014_bib0255","first-page":"633","article-title":"Platelet function recovery after ticagrelor withdrawal in patients awaiting urgent coronary surgery","volume":"51","author":"Hansson","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.tracli.2017.05.014_bib0260","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1056\/NEJMc1409373","article-title":"Inefficacy of platelet transfusion to reverse ticagrelor","volume":"372","author":"Godier","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2017.05.014_bib0265","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/jth.13576","article-title":"Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Desborough","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tracli.2017.05.014_bib0270","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jcpt.12130","article-title":"The effect of desmopressin on bleeding time and platelet aggregation in healthy volunteers administered ticagrelor","volume":"39","author":"Teng","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.tracli.2017.05.014_bib0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/EJA.0b013e32834050ab","article-title":"Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy","volume":"28","author":"Weber","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.tracli.2017.05.014_bib0280","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2016-204117","article-title":"Ticagrelor reversal: in vitro assessment of four haemostatic agents","author":"Calmette","year":"2017","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.tracli.2017.05.014_bib0285","doi-asserted-by":"crossref","DOI":"10.1111\/jth.13680","article-title":"Hemostatic effects of the ticagrelor antidote MEDI2452\u00a0in pigs treated with ticagrelor on a background of aspirin","author":"Pehrsson","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tracli.2017.05.014_bib0290","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2015-01-622928","article-title":"Structural and functional characterization of a specific antidote for ticagrelor","volume":"125","author":"Buchanan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.05.014_bib0295","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cgh.2016.07.017","article-title":"No benefit from platelet transfusion for gastrointestinal bleeding in patients taking antiplatelet agents","volume":"15","author":"Zakko","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.tracli.2017.05.014_bib0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3171\/2012.9.JNS112286","article-title":"Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral haemorrhage","volume":"118","author":"Li","year":"2013","journal-title":"J Neurosurg"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:36:07Z","timestamp":1761129367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782017300769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1246782017300769"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2017.05.014","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiplaquettaires et transfusion","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2017.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}